ask="N/A"
ask_size="N/A"
average_daily_volume="165150"
bid="12.15"
bid_size="100"
book_value="7.04"
change="+0.80"
change_from_200_day_moving_average="3.52"
change_from_50_day_moving_average="0.22"
change_from_52_week_high="-3.20"
change_From_52_week_low="8.75"
change_in_percent="+3.94%"
close="21.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18438000"
high="21.40"
high_52_weeks="24.30"
last_trade_date="2/27/2017"
last_trade_price="21.10"
last_trade_size="7529"
last_trade_time="4:00pm"
low="20.10"
low_52_weeks="12.35"
market_capitalization="601.67M"
moving_average_200_day="17.58"
moving_average_50_day="20.88"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="20.20"
pe_ratio="N/A"
peg_ratio="-0.54"
percent_change_from_200_day_moving_average="+20.05%"
percent_change_from_50_day_moving_average="+1.06%"
percent_change_from_52_week_high="-13.17%"
percent_change_from_52_week_low="+70.85%"
previous_close="20.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.88"
price_per_sales="1929.51"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="28.66"
stock_exchange="NGM"
symbol="RVNC"
volume="223644"
weeks_range_52="12.35 - 24.30"
